FRSX vs. AHI, BNZI, PRST, ASST, KWE, RTC, HKIT, RBT, APCX, and DUOT
Should you be buying Foresight Autonomous stock or one of its competitors? The main competitors of Foresight Autonomous include Advanced Health Intelligence (AHI), Banzai International (BNZI), Presto Automation (PRST), Asset Entities (ASST), KWESST Micro Systems (KWE), Baijiayun Group (RTC), Hitek Global (HKIT), Rubicon Technologies (RBT), AppTech Payments (APCX), and Duos Technologies Group (DUOT). These companies are all part of the "prepackaged software" industry.
Advanced Health Intelligence (NASDAQ:AHI) and Foresight Autonomous (NASDAQ:FRSX) are both small-cap business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, community ranking, risk, valuation, profitability, earnings, analyst recommendations and institutional ownership.
Advanced Health Intelligence has higher revenue and earnings than Foresight Autonomous.
0.0% of Advanced Health Intelligence shares are held by institutional investors. Comparatively, 23.5% of Foresight Autonomous shares are held by institutional investors. 16.0% of Advanced Health Intelligence shares are held by company insiders. Comparatively, 10.6% of Foresight Autonomous shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
In the previous week, Foresight Autonomous' average media sentiment score of 0.00 equaled Advanced Health Intelligence'saverage media sentiment score.
Foresight Autonomous received 156 more outperform votes than Advanced Health Intelligence when rated by MarketBeat users. However, 100.00% of users gave Advanced Health Intelligence an outperform vote while only 69.16% of users gave Foresight Autonomous an outperform vote.
Foresight Autonomous' return on equity of 0.00% beat Advanced Health Intelligence's return on equity.
Advanced Health Intelligence has a beta of 3.18, indicating that its share price is 218% more volatile than the S&P 500. Comparatively, Foresight Autonomous has a beta of 2.11, indicating that its share price is 111% more volatile than the S&P 500.
Summary
Advanced Health Intelligence beats Foresight Autonomous on 7 of the 10 factors compared between the two stocks.
Get Foresight Autonomous News Delivered to You Automatically
Sign up to receive the latest news and ratings for FRSX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding FRSX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Foresight Autonomous Competitors List
Related Companies and Tools